Portland, Maine, September 6, 2025 — Public health officials in Maine have confirmed three new active tuberculosis (TB) cases in the Greater Portland region, reigniting concern over the re-emergence of one of the world’s oldest and deadliest infectious diseases. According to the Maine Center for Disease Control and Prevention (Maine CDC), the cases are not linked to each other, pointing to separate sources of infection rather than a localized outbreak.
Maine’s Rising Case Count
The latest cases bring Maine’s cumulative TB tally to 28 confirmed cases by July 2025, a figure that already surpasses previous years’ averages. By comparison, Maine reported only 17 cases in 2023. While small in absolute numbers, the jump signals an unsettling trend in a state historically considered low-incidence.
Officials emphasize that comprehensive contact tracing, testing, and preventive therapy have been activated. “These are isolated cases, but vigilance is crucial. TB remains treatable, yet dangerous if undetected,” a Maine CDC spokesperson said.
The Global Burden of TB
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, is responsible for 1.25 million deaths globally each year, according to the World Health Organization (WHO). Despite significant advances in treatment, TB continues to outpace other infectious diseases—including HIV/AIDS—as the world’s deadliest single pathogen.
The WHO estimates nearly 10 million people worldwide fell ill with TB in 2023. The disease disproportionately affects low- and middle-income nations, but rising migration, waning surveillance, and healthcare disparities have seen cases tick upward again in developed economies.
Trends Across the United States
Nationally, TB incidence in the U.S. has shown a slow but steady increase since the COVID-19 pandemic disrupted screening programs. The U.S. Centers for Disease Control and Prevention (CDC) reported 9,615 TB cases in 2023, a 5% rise from 2022, and the highest since 2013. Deaths have also crept upward, with 565 TB-related fatalities recorded in 2022.
In recent years, outbreaks have clustered in states with large migrant or transient worker populations. Kansas, for example, experienced one of the largest TB surges in decades, recording 113 cases in 2024, largely linked to community spread among vulnerable groups.
Why TB Persists
Epidemiologists highlight several factors driving TB’s persistence:
- Undiagnosed Latent TB: Up to 13 million Americans may carry latent TB infection, which can activate under weakened immunity.
- Drug Resistance: Multidrug-resistant TB (MDR-TB) accounts for a growing share of cases worldwide, with U.S. authorities monitoring resistant strains closely.
- Healthcare Gaps: Rural areas like Maine often lack rapid diagnostic facilities, delaying treatment.
- Post-Pandemic Lag: The COVID-19 crisis diverted resources away from TB detection, creating a backlog in testing and follow-up.
Treatment and Prevention
Fortunately, TB remains treatable with a 6- to 12-month antibiotic regimen when detected early. Maine health officials have assured that all confirmed patients are receiving treatment under supervised care, with close contacts being screened for latent infection.
Experts stress the importance of early testing, particularly among high-risk groups such as healthcare workers, recent migrants from TB-endemic countries, and immunocompromised individuals.
Looking Ahead
The Maine CDC expects sporadic TB cases to continue surfacing but maintains that robust surveillance and public awareness can keep the disease under control. However, public health researchers caution that rising numbers—even in low-incidence states—signal a broader U.S. vulnerability as TB adapts to globalized movement and uneven healthcare systems.
For now, the message remains clear: TB, once thought a relic of the past in wealthier nations, is reasserting itself as a public health challenge requiring vigilance, sustained funding, and international cooperation.
